Antitumor activity of the yeast mannan preparation in relation to the effect of chemical modification.
D000215:Acylation; D000284:Administration, Oral; D000818:Animals; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000627:therapeutic use* / Q000633:toxicity; D002175:Candida; D005260:Female; D006868:Hydrolysis; D007274:Injections, Intraperitoneal; D007275:Injections, Intravenous; D007279:Injections, Subcutaneous; D008297:Male; D008745:Methylation; D051379:Mice; D008970:Molecular Weight; D009368:Neoplasm Transplantation; D011134:Polysaccharides / Q000008:administration & dosage / Q000627:therapeutic use* / Q000633:toxicity; D012510:Sarcoma 180 / Q000188:drug therapy*
D000970:Antineoplastic Agents; D011134:Polysaccharides